Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism

Molecular Pharmacology

Volumn 68, Issue 5, 2005, Pages 1214-1224

  Salthun Lassalle, Bénédicte ^a   Traver, Sabine ^a   Hirsch, Etienne C ^a   Michel, Patrick P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOVALERYLSUBSTANCE P [7-11][9 PROLINE 10 (N METHYLLEUCINE)]; [PROLINE 9 (SPIRO GAMMA LACTAM]LEUCINE 10,TRYPTOPHAN 11]SUBSTANCE P; CALCIUM CHANNEL N TYPE; N [ALPHA (METHOXYCARBONYL)BENZYL] 2 PHENYL 4 QUINOLINECARBOXAMIDE; NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR AGONIST; NEUROKININ 3 RECEPTOR ANTAGONIST; NEUROKININ A; NEUROKININ A [3-10][3 LYSINE 8 GLYCINE GAMMA LACTAM 9 LEUCINE]; NEUROKININ B; NEUROTROPHIC FACTOR; OMEGA CONOTOXIN MVIIA; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR ANTAGONIST; TETRODOTOXIN; TRITIUM; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; GLIA CELL; MESENCEPHALON; MODEL; NERVE CELL CULTURE; NERVE CELL NECROSIS; NERVE EXCITABILITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM CHANNELS, N-TYPE; CELL COUNT; CELL SURVIVAL; DOPAMINE; ION CHANNEL GATING; MESENCEPHALON; NEUROKININ A; NEUROKININ B; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-3; SODIUM CHANNELS; SUBSTANCE P; TETRODOTOXIN;

EID: 27544502293     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.015453     Document Type: Article

References (41)

1. Agid Y (1991) Parkinson's disease: pathophysiology. Lancet 337:1321-1324.
2. Bayguinov O, Hagen B, and Sanders KM (2003) Substance P modulates localized calcium transients and membrane current responses in murine colonic myocytes. Br J Pharmacol 138:1233-1243.
3. Betarbet R and Greenamyre JT (2004) Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP. Exp Neurol 189:393-403.
4. Calvo N, Reiriz J, Perez-Navarro E, and Alberch J (1996) Tachykinins protect cholinergic neurons from quinolinic acid excitotoxicity in striatal cultures. Brain Res 740:323-328.
5. Catterall WA (1980) Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Annu Rev Pharmacol Toxicol 20:15-43.
6. Chen LW, Guan ZL, and Ding YQ (1998) Mesencephalic dopaminergic neurons expressing neuromedin K receptor (NK3): a double immunocytochemical study in the rat. Brain Res 780:150-154.
7. Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, Davidson BL, and Bohn MC (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science (Wash DC) 275:838-841.
8. Dauer W and Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909.
9. Dawson TM and Dawson VL (2002) Neuroprotective and neurorestorative strategies for Parkinson's disease. Nat Neurosci 5 (Suppl):1058-1061.
10. + requires concurrent inactivation of NMDA or AMPA/kainate receptors. J Neurochem 78:163-174.
11. Friedman WJ, Dreyfus CF, McEwen B, and Black IB (1988) Presynaptic transmitters and depolarizing influences regulate development of the substantia nigra in culture. J Neurosci 8:3616-3623.
12. Friedman Y, Richter A, Raymond R, Loscher W, and Nobrega JN (2002) Regional decreases in NK-3, but not NK-1 tachykinin receptor binding in dystonic hamster (dt(sz)) brains. Neuroscience 112:639-645.
13. Futami T, Hatanaka Y, Matsushita K, and Furuya S (1998) Expression of substance P receptor in the substantia nigra. Brain Res Mol Brain Res 54:183-198.
14. Hammond C (2001) Subliminal voltage-gated currents of the somato-dendritic membrane, in Cellular and Molecular Neurobiology, pp 358-373, Academic Press, London.
15. 2+ channel. Eur J Pharmacol 321:217-223.
16. Hirsch E, Graybiel AM, and Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature (Lond) 334:345-348.
17. Hokfelt T, Reid M, Herrera-Marschitz M, Ungerstedt U, Terenius L, Hakanson R, Feng DM, and Folkers K (1991) Tachykinins and related peptides in the substantia nigra and neostriatum. Ann NY Acad Sci 632:192-197.
18. Humpel C, Marksteiner J, and Saria A (1996) Glial-cell-line-derived neurotrophic factor enhances biosynthesis of substance P in striatal neurons in vitro. Cell Tissue Res 286:249-255.
19. Ikeda H, Heinke B, Ruscheweyh R, and Sandkuhler J (2003) Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science (Wash DC) 299:1237-1240.
20. Katsuki H, Takenaka C, Kume T, Kaneko S, and Akaike A (2001) Requirement of neural activity for the maintenance of dopaminergic neurons in rat midbrain slice cultures. Neurosci Lett 300:166-170.
21. Khawaja AM and Rogers DF (1996) Tachykinins: receptor to effector. Int J Biochem Cell Biol 28:721-738.
22. Kowall NW, Beal MF, Busciglio J, Duffy LK, and Yankner BA (1991) An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc Natl Acad Sci USA 88:7247-7251.
23. 2+-MAPK/ERK pathways. J Neurochem 87:508-521.
24. Mauborgne A, Javoy-Agid F, Legrand JC, Agid Y, and Cesselin F (1983) Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains. Brain Res 268:167-170.
25. Michel PP and Agid Y (1996) Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J Neurochem 67:1633-1642.
26. Michel PP, Marien M, Ruberg M, Colpaert F, and Agid Y (1999) Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes. J Neurochem 72:2074-2082.
27. Mourlevat S, Troadec JD, Ruberg M, and Michel PP (2003) Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytes. Mol Pharmacol 64:578-586.
28. Nalivaiko E, Michaud JC, Soubrie P, Le Fur G, and Feltz P (1997) Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study. Neuroscience 78:745-757.
29. National Research Council (1996) Guide for the Care and Use of Laboratory Animals, National Academies Press, Washington, DC.
30. Ogun-Muyiwa P, Helliwell R, McIntyre P, and Winter J (1999) Glial cell line derived neurotrophic factor (GDNF) regulates VR1 and substance P in cultured sensory neurons. Neuroreport 10:2107-2111.
31. Oo TF, Kholodilov N, and Burke RE (2003) Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo. J Neurosci 23:5141-5148.
32. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, and Maggi CA (2004) Tachykinins and tachykinin receptors: a growing family. Life Sci 74:1445-1463.
33. Pinto FM, Armesto CP, Magraner J, Trujillo M, Martin JD, and Candenas ML (1999) Tachykinin receptor and neutral endopeptidase gene expression in the rat uterus: characterization and regulation in response to ovarian steroid treatment. Endocrinology 140:2526-2532.
34. Rothman TP, Specht LA, Gershon MD, Joh TH, Teitelman G, Pickel VM, and Reis DJ (1980) Catecholamine biosynthetic enzymes are expressed in replicating cells of the peripheral but not the central nervous system. Proc Natl Acad Sci USA 77:6221-6225.
35. Salthun-Lassalle B, Hirsch EC, Wolfart J, Ruberg M, and Michel PP (2004) Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J Neurosci 24:5922-5930.
36. Santi CM, Cayabyab FS, Sutton KG, McRory JE, Mezeyova J, Hamming KS, Parker D, Stea A, and Snutch TP (2002) Differential inhibition of T-type calcium channels by neuroleptics. J Neurosci 22:396-403.
37. 2+ channels in DRG neurons of the adult rat. J Neurophysiol 90:21-31.
38. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, and Erspamer V (2002) The tachykinin peptide family. Pharmacol Rev 54:285-322.
39. Stacey AE, Woodhall GL, and Jones RS (2002) Neurokinin-receptor-mediated depolarization of cortical neurons elicits an increase in glutamate release at excitatory synapses. Eur J Neurosci 16:1896-1906.
40. 1/2) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. Mol Pharmacol 62:1043-1052.
41. Yang YL, Yao KH, and Li ZW (2003) Similarities of SP-, NKA- and NKB-induced currents in rat dorsal root ganglion neurons. Brain Res 991:18-25.